104 filings
6-K
ASLN
ASLAN Pharmaceuticals Ltd
9 May 24
Aslan Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:10am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
7 May 24
Current report (foreign)
7:41am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
22 Apr 24
Aslan Pharmaceuticals Announces Positive Interim Results from Phase 2 Study of Eblasakimab In Dupilumab-experienced Atopic Dermatitis Patients
8:29am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
19 Apr 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Notice
5:01pm
6-K
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Amendment No. 2 to the Open Market Sale Agreementsm
8:10am
6-K
idf1tkbn xeu5tgw0ens
12 Apr 24
Aslan Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:05am
6-K
1dx7qoo3ate6822q9
13 Mar 24
Aslan Pharmaceuticals Announces $5 Million Registered Direct Offering
7:27am
6-K
vvqhyp1zcm
11 Mar 24
ASLAN PHARMACEUTICALS PROVIDES TREK-DX STUDY UPDATE AND HIGHLIGHTS potENTIAL of EBLASAKIMAB in DUPILUMAB-EXPERIENCED ATOPIC DERMATITIS PATIENTS
8:03am
6-K
4gcwnats cs
24 Jan 24
Current report (foreign)
7:52am
6-K
o8j9f
8 Jan 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
7:02am
6-K
kpupoxe eeg2
22 Dec 23
Current report (foreign)
4:24pm
6-K
ji5e8p
8 Dec 23
Current report (foreign)
4:42pm
6-K
i05ok8rf4wm5 i0nb
27 Oct 23
Aslan Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:14am
6-K
zslni6fe5bul 9z0to4l
24 Oct 23
Aslan Pharmaceuticals to Co-host Kol Panel Discussion Today on Changes In the Clinical Trial and Treatment Landscape for Atopic Dermatitis
8:32am
6-K
p41 spdcuo7wft7f5vab
16 Oct 23
Current report (foreign)
6:08am
6-K/A
snuzb0ps
18 Aug 23
Current report (foreign) (amended)
7:33am
6-K
otcqzhv3bofthucsmg
11 Aug 23
Aslan Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
jmak15q3yec739qnd0v
20 Jul 23
Current report (foreign)
7:55am
6-K
ca2cv q1w
6 Jul 23
Current report (foreign)
8:11am
6-K
b62su7 2i7vl5
6 Jul 23
Current report (foreign)
7:59am